New hope for brain cancer? experimental combo targets glioblastoma
NCT ID NCT06102525
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 26 times
Summary
This early-stage study tests a new drug called RZ-001 combined with valganciclovir in people with glioblastoma, a serious brain cancer. The goal is to find a safe dose and see if the treatment can shrink tumors or help people live longer. About 43 adults with a specific tumor marker (hTERT) will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, 05505, South Korea
Contact
-
Gachon University Gil Medical Center
RECRUITINGIncheon, 21565, South Korea
Contact
-
Samsung Medical Center
RECRUITINGSeoul, 06351, South Korea
Contact
-
Seoul National University Bundang Hospital
RECRUITINGSeongnam-si, 13620, South Korea
Contact
-
Severance Hospital, Yonsei University Health System
RECRUITINGSeoul, 03722, South Korea
Contact
-
The Catholic University of Korea, Incheon St. Mary's Hospital
RECRUITINGIncheon, 21431, South Korea
Contact
Conditions
Explore the condition pages connected to this study.